AS
ALGENSCRIBE SAS
The startup has developed a genome editing platform that utilizes a unique toolbox for precise homologous recombination, enhancing the efficiency of gene modification. This technology addresses the limitations of traditional nuclease-based genome editing methods, enabling the creation of more effective therapeutics for human health.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$480KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup has developed a genome editing platform that utilizes a unique toolbox for precise homologous recombination, enhancing the efficiency of gene modification. This technology addresses the limitations of traditional nuclease-based genome editing methods, enabling the creation of more effective therapeutics for human health.